Latest Breaking News On - Switch proteins - Page 1 : comparemela.com

Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology Patents to the European Patent Office

Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology Patents to the European Patent Office
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Pamela keckPlanegg martinsriedUnitope traEuropean patent officePrime standardEuropean patentEnd to platformSwitch proteins

Medigene AG Expands Its End-To-End Platform By Submitting Three Development Optimization Technology Patents To The European Patent Office

Planegg martinsriedUnitope traPamela keckEuropean patent officePrime standardEuropean patentEnd to platformSwitch proteins

Medigene s Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announced Term

Planegg/Martinsried, May 21, 2024. Medigene AG , an immuno-oncology platform company focusing on the discovery and development of differentiated T cell immunotherapies for solid tumors and BioNTech SE.

Planegg martinsriedPamela keckPrime standardChief executive officerEnd to platformSwitch proteinsProgrammed death ligand

Medigene s Global Research & Collaboration Agreement with BioNTech to Extend Beyond

Planegg/Martinsried, May 21, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of differentiated T cell immunotherapies for

Pamela keckPlanegg martinsriedPrime standardChief executive officerEnd to platformSwitch proteinsSwitch proteinProgrammed death ligand

Medigene Presents at CAR-TCR Summit Europe Showcasing Unique Approach for Development of

Multiple members of management as expert speakers including Prof. Dr. Dolores Schendel, Chief Scientific Officer of Medigene, Dr. Barbara Lösch, Head of Technology & Innovation and Dr. Kirsty Crame, Vice

City ofUnited kingdomKirsty cramePamela keckDolores schendelPlanegg martinsriedVp clinical strategy developmentHead of technology innovationClinical strategy developmentChief scientific officerVice presidentClinical strategyEnd to platformPrime standardModular controlCell therapies